Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
Dose-Range Finding Study for MK0893 (0893-008)
This study has been terminated.
( Sufficient data regarding the dose-response to MK-0893 had been obtained from the first cohort of the study to assess the safety and efficacy )
Study NCT00479466 Information provided by Merck Sharp & Dohme Corp.
First Received on May 25, 2007. Last Updated on October 15, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetes Mellitus, Type 2
Additional conditions recognized in this trial
More general conditions related to this trial
Endocrine System Diseases
Glucose Metabolism Disorders
Interventions listed in this trial
Placebo to MK0893
Placebo to Metformin
More general drug interventions related to this trial
Physiological Effects of Drugs
Sponsors listed in this trial
Merck Sharp & Dohme Corp.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers